Seniors with cancer respond just as well as younger patients to immune checkpoint inhibitors -- drugs that take the brakes ...

Older adults with cancer respond just as well as younger patients to immune checkpoint inhibitors despite age-related immune ...

Removing EPO signalling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.

Older adults with cancer respond just as well as younger patients to immune checkpoint inhibitors despite age-related immune system differences, according to a study by researchers from the Johns ...

Older adults with cancer respond just as well as younger patients to immune checkpoint inhibitors despite age-related immune system differences, according to a new study.

A man with a life-threatening peanut allergy is living a near-normal life after taking part in a “life-changing” study which gradually saw him exposed to nuts ...

Mark Litzow, MD, discusses the challenges of using immunotherapy for the treatment of acute lymphoblastic leukemia.

Researchers at Moffitt Cancer Center have found that tapping into the body’s own immune system and activating a type of immune cell known as B cells, could be the key to boosting the effectiveness of ...

The study reexamined immunotherapy clinical trial data on bladder and skin cancer and found that “cold” tumors, ones that haven’t yet been infiltrated by immune cells, are just as vulnerable to ...

Results of their study were published in the Journal for Immunotherapy of Cancer. TIL therapy starts with doctor's removing tumors from the patient. These tumors are sent to a lab, where they are ...

TAIPEI (Taiwan News) — A study by Chang Gung Memorial Hospital has discovered that removing the amino acid asparagine from immune cells can significantly enhance their cancer-fighting ability, ...